Literature DB >> 23806580

Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.

Elson Asevedo1, Ary Gadelha, Cristiano Noto, Rodrigo B Mansur, André Zugman, Síntia I N Belangero, Arthur A Berberian, Bruno S Scarpato, Emilie Leclerc, Antônio L Teixeira, Clarissa S Gama, Rodrigo A Bressan, Elisa Brietzke.   

Abstract

OBJECTIVE: To investigate possible differences in peripheral levels of chemokines, BDNF and oxidative markers between patients with Schizophrenia (SZ) and matched healthy controls, and investigate the correlation of these biomarkers with cognitive performance.
METHODS: Thirty individuals with SZ and 27 healthy controls were included and the following plasmatic biomarkers' levels were determined according to manufacturers' instructions: BDNF, TBARS, protein carbonyl content (PCC) and the chemokines CXCL-10/IP-10, CXCL-8/IL-8, CCL-11, CCL-24/Eotaxin-2, CCL-2/MCP-1, CCL-3/MIP-1. Selected neuropsychological tasks were administered to assess verbal learning (Hopkins Verbal Learning Test), verbal fluency (FAS test), working memory (Visual Working Memory Task, Keep Track Task, Letter Memory Task), set shifting (Plus-minus task, Number-letter task), inhibition (Computerized Stroop Task, Semantic Generation Task) and complex executive function tasks (Tower of London and the shortened version of the WCST-64).
RESULTS: Compared with the healthy control group, individuals with SZ presented significantly higher levels of BDNF and the chemokine CCL-11, and lower levels of TBARS and the chemokine CXCL-10/IP-10. When we examined only the SZ group, BDNF levels were positively correlated with semantic generation tasks. Working memory ability was negatively correlated with PCC. Regarding chemokines, CCL-11 was negatively correlated to performance in working memory test, and positively correlated with cognitive flexibility task. CXCL-8/IL-8 was positively correlated with verbal fluency. CCL-24/Eotaxin-2 was positively correlated with semantic generation ability and letter memory task.
CONCLUSIONS: Our results indicate that cognitive performance in SZ is associated with mediators of neuroplasticity that can be measured peripherally.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BDNF; Biomarkers; Chemokines; Cognition; Oxidative stress; Schizophrenia

Mesh:

Substances:

Year:  2013        PMID: 23806580     DOI: 10.1016/j.jpsychires.2013.05.032

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  21 in total

1.  Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.

Authors:  Katharina Janssen; Mira Rickert; Tim Clarner; Cordian Beyer; Markus Kipp
Journal:  Mol Neurobiol       Date:  2015-02-08       Impact factor: 5.590

2.  Correlates of early pregnancy serum brain-derived neurotrophic factor in a Peruvian population.

Authors:  Na Yang; Elizabeth Levey; Bizu Gelaye; Qiu-Yue Zhong; Marta B Rondon; Sixto E Sanchez; Michelle A Williams
Journal:  Arch Womens Ment Health       Date:  2017-07-27       Impact factor: 3.633

Review 3.  Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics.

Authors:  Chi-Yu Lai; Elizabeth Scarr; Madhara Udawela; Ian Everall; Wei J Chen; Brian Dean
Journal:  World J Psychiatry       Date:  2016-03-22

4.  Oxidative stress and BDNF as possible markers for the severity of crack cocaine use in early withdrawal.

Authors:  Anne Orgle Sordi; Flavio Pechansky; Felix Henrique Paim Kessler; Flávio Kapczinski; Bianca Pfaffenseller; Carolina Gubert; Bianca Wollenhaupt de Aguiar; Joana Correa de Magalhães Narvaez; Felipe Ornell; Lisia von Diemen
Journal:  Psychopharmacology (Berl)       Date:  2014-03-28       Impact factor: 4.530

Review 5.  Potential drug targets and treatment of schizophrenia.

Authors:  Anil Kumar; Monu Yadav; Milind Parle; Sameer Dhingra; Dinesh K Dhull
Journal:  Inflammopharmacology       Date:  2017-03-28       Impact factor: 4.473

6.  The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis.

Authors:  M Morrens; C Overloop; V Coppens; E Loots; M Van Den Noortgate; S Vandenameele; M Leboyer; L De Picker
Journal:  Mol Psychiatry       Date:  2022-04-28       Impact factor: 15.992

7.  Serum brain-derived neurotrophic factor (BDNF) concentrations in pregnant women with post-traumatic stress disorder and comorbid depression.

Authors:  Na Yang; Bizu Gelaye; Qiuyue Zhong; Marta B Rondon; Sixto E Sanchez; Michelle A Williams
Journal:  Arch Womens Ment Health       Date:  2016-05-19       Impact factor: 3.633

8.  Chronic Intermittent Hypobaric Hypoxia Pretreatment Ameliorates Ischemia-Induced Cognitive Dysfunction Through Activation of ERK1/2-CREB-BDNF Pathway in Anesthetized Mice.

Authors:  Jintian Wang; Shixiao Zhang; Huijuan Ma; Shijie Yang; Zhao Liu; Xiaolei Wu; Sheng Wang; Yi Zhang; Yixian Liu
Journal:  Neurochem Res       Date:  2016-11-08       Impact factor: 3.996

9.  Abnormalities in chemokine levels in schizophrenia and their clinical correlates.

Authors:  Suzi Hong; Ellen E Lee; Averria Sirkin Martin; Benchawanna Soontornniyomkij; Virawudh Soontornniyomkij; Cristian L Achim; Chase Reuter; Michael R Irwin; Lisa T Eyler; Dilip V Jeste
Journal:  Schizophr Res       Date:  2016-09-17       Impact factor: 4.939

10.  Chemokine MCP1 is associated with cognitive flexibility in schizophrenia: A preliminary analysis.

Authors:  Federica Klaus; Kyle Mitchell; Sharon C Liou; Lisa T Eyler; Tanya T Nguyen
Journal:  J Psychiatr Res       Date:  2021-04-03       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.